Cenovus Energy (CVE) slides as crude prices retreat, pressuring upstream-heavy energy names

Cenovus Energy (CVE) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks primarily tied to a broad pullback in crude oil prices, which can quickly pressure oil-weighted producers like Cenovus. With no obvious company-specific headline driving trading, the decline likely reflects macro/commodity sensitivity after a volatile stretch for oil markets.

Details:

Crude oil prices fell sharply in the latest session, giving back a portion of recent gains after a volatile period for energy markets.

Cenovus has significant upstream exposure (including Canadian oil sands production), so its cash-flow expectations and near-term sentiment often track crude benchmarks.

Energy shares that rallied during prior oil spikes can see outsized pullbacks on down-oil days as traders rebalance risk and take profits.

Recent company items (such as quarterly updates and shareholder-return framework details) appear to be known information, suggesting today’s move is more commodity-driven than news-driven.

Sources:

Associated Press, Trading Economics, Cenovus Energy

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CVE Hedge Fund Activity

We have seen 256 institutional investors add shares of $CVE stock to their portfolio, and 219 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS removed 36,579,989 shares (-32.5%) from their portfolio in Q1 2026, for an estimated $970,467,108
PRICE T ROWE ASSOCIATES INC /MD/ added 23,907,299 shares (+inf%) to their portfolio in Q1 2026, for an estimated $634,260,642
CAPITAL RESEARCH GLOBAL INVESTORS removed 19,067,968 shares (-15.3%) from their portfolio in Q1 2026, for an estimated $505,873,191
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 14,895,479 shares (-96.6%) from their portfolio in Q1 2026, for an estimated $395,177,057
BANK OF AMERICA CORP /DE/ added 11,992,596 shares (+111.3%) to their portfolio in Q1 2026, for an estimated $318,163,571
GOLDMAN SACHS GROUP INC added 8,889,079 shares (+115.5%) to their portfolio in Q1 2026, for an estimated $235,827,265
VANGUARD GROUP INC added 7,197,843 shares (+12.8%) to their portfolio in Q4 2025, for an estimated $121,787,503

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CVE Analyst Ratings

Wall Street analysts have issued reports on $CVE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Scotiabank issued a "Sector Outperform" rating on 05/07/2026

To track analyst ratings and price targets for $CVE, check out Quiver Quantitative's $CVE forecast page.

$CVE Price Targets

Multiple analysts have issued price targets for $CVE recently. We have seen 4 analysts offer price targets for $CVE in the last 6 months, with a median target of $44.0.

Here are some recent targets:

Kevin Fisk from Scotiabank set a target price of $47.0 on 05/20/2026
Greg Pardy from RBC Capital set a target price of $47.0 on 05/19/2026
Manav Gupta from UBS set a target price of $41.0 on 04/09/2026
Neil Mehta from Goldman Sachs set a target price of $29.0 on 03/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.